Abstract
Nitric oxide (NO) plays a significant role in vasodilation, platelet aggregation, neurotransmission and many other physiological processes, and in most of these cases it works through activation of soluble guanylyl cyclase and elevation of cyclic GMP concentration. Soluble guanylyl cyclase is a heterodimeric protein made up of one α and one β subunit. The β subunit has one molecule of heme attached to it through a histidine residue. NO activates the enzyme by binding to the heme iron and weakening its bond to the histidine. Carbon monoxide activates the enzyme only marginally, but can activate to the level achieved by NO in the presence of allosteric regulators such as YC-1. Upon dissociation of NO, the enzyme becomes deactivated. In some cells, exposure to NO may result in rapid desensitization of the enzyme, thus preventing undesirable consequences of continued, unabated cyclic GMP production.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference
Azam M et al (1998) Genetic mapping of soluble guanylyl cyclase genes: implications for linkage to blood pressure in the Dahl rat. Hypertension 32(1):149–154
Bailly C (1998) Transducing pathways involved in the control of NaCl reabsorption in the thick ascending limb of Henle’s loop. Kidney Int Suppl 65:S29–S35
Behrends S, Vehse K (2000) The beta (2) subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma. Biochem Biophys Res Commun 271(1):64–69
Bellamy TC et al (2000) Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses. Proc Natl Acad Sci USA 97(6):2928–2933
Bellamy TC, Wood J, Garthwaite J (2002) On the activation of soluble guanylyl cyclase by nitric oxide. Proc Natl Acad Sci USA 99(1):507–510
Bivalacqua TJ et al (2000) Adenoviral gene transfer of endothelial nitric oxide synthase (eNOS) to the penis improves age-related erectile dysfunction in the rat. Int J Impot Res 12(Suppl. 3):S8–S17
Boulton CL, Southam E, Garthwaite J (1995) Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69(3):699–703
Brandes RP et al (2000) Increased nitrovasodilator sensitivity in endothelial nitric oxide synthase knockout mice: role of soluble guanylyl cyclase. Hypertension 35(1 Pt 2):231–236
Brandish PE, Buechler W, Marletta MA (1998) Regeneration of the ferrous heme of soluble guanylate cyclase from the nitric oxide complex: acceleration by thiols and oxyhemoglobin. Biochemistry 37(48):16898–16907
Bredt DS, Snyder SH (1992) Nitric oxide, a novel neuronal messenger. Neuron 8(1):3–11
Breer H, Shepherd GM (1993) Implications of the NO/cGMP system for olfaction. Trends Neurosci 16(1):5–9
Brune B, Ullrich V (1987) Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 32(4):497–504
Burstyn JN et al (1995) Studies of the heme coordination and ligand binding properties of soluble guanylyl cyclase (sGC): characterization of Fe(II) sGC and Fe(II) sGC(CO) by electronic absorption and magnetic circular dichroism spectroscopies and failure of CO to activate the enzyme. Biochemistry 34(17):5896–5903
Cary SP, Winger JA, Marletta MA (2005) Tonic and acute nitric oxide signaling through soluble guanylate cyclase is mediated by nonheme nitric oxide, ATP, and GTP. Proc Natl Acad Sci USA 102(37):13064–13069
Chen ZJ et al (2001) 17beta-estradiol inhibits soluble guanylate cyclase activity through a protein tyrosine phosphatase in PC12 cells. J Steroid Biochem Mol Biol 78(5):451–458
Cherry PD et al (1982) Role of endothelial cells in relaxation of isolated arteries by bradykinin. Proc Natl Acad Sci USA 79(6):2106–2110
Chinkers M, Wilson EM (1992) Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant. J Biol Chem 267(26):18589–18597
Derbyshire ER, Marletta MA (2007) Butyl isocyanide as a probe of the activation mechanism of soluble guanylate cyclase. Investigating the role of non-heme nitric oxide. J Biol Chem 282(49):35741–35748
Dierks EA, Burstyn JN (1998) The deactivation of soluble guanylyl cyclase by redox-active agents. Arch Biochem Biophys 351(1):1–7
Dizhoor AM (2000) Regulation of cGMP synthesis in photoreceptors: role in signal transduction and congenital diseases of the retina. Cell Signal 12(11–12):711–719
Ferrero R et al (2000) Nitric oxide-sensitive guanylyl cyclase activity inhibition through cyclic GMP-dependent dephosphorylation. J Neurochem 75(5):2029–2039
Forstermann U et al (1994) Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 23(6 Pt 2):1121–1131
Friebe A, Koesling D (1998) Mechanism of YC-1-induced activation of soluble guanylyl cyclase. Mol Pharmacol 53(1):123–127
Friebe A, Schultz G, Koesling D (1996) Sensitizing soluble guanylyl cyclase to become a highly CO-sensitive enzyme. Embo J 15(24):6863–6868
Friebe A et al (1997) Functions of conserved cysteines of soluble guanylyl cyclase. Biochemistry 36(6):1194–1198
Friebe A et al (1999) A point-mutated guanylyl cyclase with features of the YC-1-stimulated enzyme: implications for the YC-1 binding site? Biochemistry 38(46):15253–15257
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288(5789):373–376
Gerzer R et al (1981) Soluble guanylate cyclase purified from bovine lung contains heme and copper. FEBS Lett 132(1):71–74
Gibb BJ, Wykes V, Garthwaite J (2003) Properties of NO-activated guanylyl cyclases expressed in cells. Br J Pharmacol 139(5):1032–1040
Gibson AD, Garbers DL (2000) Guanylyl cyclases as a family of putative odorant receptors. Annu Rev Neurosci 23:417–439
Gupta G et al (1997) The beta2 subunit inhibits stimulation of the alpha1/beta1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure. J Clin Invest 100(6):1488–1492
Harteneck C et al (1990) Expression of soluble guanylyl cyclase. Catalytic activity requires two enzyme subunits. FEBS Lett 272(1–2):221–223
Harteneck C et al (1991) Molecular cloning and expression of a new alpha-subunit of soluble guanylyl cyclase. Interchangeability of the alpha-subunits of the enzyme. FEBS Lett 292(1–2):217–222
Huganir RL, Greengard P (1990) Regulation of neurotransmitter receptor desensitization by protein phosphorylation. Neuron 5(5):555–567
Ignarro LJ et al (1981) Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J Pharmacol Exp Ther 218(3):739–749
Ignarro LJ et al (1982a) Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung. Biochim Biophys Acta 718(1):49–59
Ignarro LJ, Wood KS, Wolin MS (1982b) Activation of purified soluble guanylate cyclase by protoporphyrin IX. Proc Natl Acad Sci USA 79(9):2870–2873
Ignarro LJ, Wood KS, Wolin MS (1984) Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Adv Cyclic Nucleotide Protein Phosphorylation Res 17:267–274
Ignarro LJ et al (1987) Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84(24):9265–9269
Jones MV, Westbrook GL (1996) The impact of receptor desensitization on fast synaptic transmission. Trends Neurosci 19(3):96–101
Kaehler ST et al (1999) Nitric oxide modulates the release of serotonin in the rat hypothalamus. Brain Res 835(2):346–349
Karow DS et al (2005) Characterization of functional heme domains from soluble guanylate cyclase. Biochemistry 44(49):16266–16274
Katsuki S et al (1977) Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine. J Cyclic Nucleotide Res 3(1):23–35
Kharitonov VG et al (1997a) Kinetics of nitric oxide dissociation from five- and six-coordinate nitrosyl hemes and heme proteins, including soluble guanylate cyclase. Biochemistry 36(22):6814–6818
Kharitonov VG et al (1997b) Dissociation of nitric oxide from soluble guanylate cyclase. Biochem Biophys Res Commun 239(1):284–286
Kharitonov VG et al (1999) Kinetics and equilibria of soluble guanylate cyclase ligation by CO: effect of YC-1. Biochemistry 38(33):10699–10706
Ko FN et al (1994) YC-1, a novel activator of platelet guanylate cyclase. Blood 84(12):4226–4233
Koesling D et al (1988) The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase. FEBS Lett 239(1):29–34
Koesling D et al (1990) The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. Homology between the two subunits of the enzyme. FEBS Lett 266(1–2):128–132
Koglin M et al (2001) Nitric oxide activates the beta 2 subunit of soluble guanylyl cyclase in the absence of a second subunit. J Biol Chem 276(33):30737–30743
Lawson DM et al (2003) A two-faced molecule offers NO explanation: the proximal binding of nitric oxide to haem. Biochem Soc Trans 31(Pt 3):553–557
Lincoln TM, Cornwell TL (1993) Intracellular cyclic GMP receptor proteins. Faseb J 7(2):328–338
Liu Y et al (1997) Catalytic mechanism of the adenylyl and guanylyl cyclases: modeling and mutational analysis. Proc Natl Acad Sci USA 94(25):13414–13419
Louis JC, Revel MO, Zwiller J (1993) Activation of soluble guanylate cyclase through phosphorylation by protein kinase C in intact PC12 cells. Biochim Biophys Acta 1177(3):299–306
Lucas KA et al (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol Rev 52(3):375–414
Margulis A, Sitaramayya A (2000) Rate of deactivation of nitric oxide-stimulated soluble guanylate cyclase: influence of nitric oxide scavengers and calcium. Biochemistry 39(5):1034–1039
Marsh N, Marsh A (2000) A short history of nitroglycerine and nitric oxide in pharmacology and physiology. Clin Exp Pharmacol Physiol 27(4):313–319
Moncada S et al (1991) Development and mechanism of a specific supersensitivity to nitrovasodilators after inhibition of vascular nitric oxide synthesis in vivo. Proc Natl Acad Sci USA 88(6):2166–2170
Moro MA et al (1996) cGMP mediates the vascular and platelet actions of nitric oxide: confirmation using an inhibitor of the soluble guanylyl cyclase. Proc Natl Acad Sci USA 93(4):1480–1485
Mullershausen F, Koesling D, Friebe A (2005) NO-sensitive guanylyl cyclase and NO-induced feedback inhibition in cGMP signaling. Front Biosci 10:1269–1278
Mullershausen F et al (2006) Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways. Mol Pharmacol 69(6):1969–1974
Murthy KS (2001) Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle. Biochem J 360(Pt 1):199–208
Parma J et al (1991) Sequence of a human brain adenylyl cyclase partial cDNA: evidence for a consensus cyclase specific domain. Biochem Biophys Res Commun 179(1):455–462
Radomski MW, Palmer RM, Moncada S (1987) The role of nitric oxide and cGMP in platelet adhesion to vascular endothelium. Biochem Biophys Res Commun 148(3):1482–1489
Roy B, Garthwaite J (2006) Nitric oxide activation of guanylyl cyclase in cells revisited. Proc Natl Acad Sci USA 103(32):12185–12190
Roy B, Halvey EJ, Garthwaite J (2008) An enzyme-linked receptor mechanism for nitric oxide-activated guanylyl cyclase. J Biol Chem 283(27):18841–18851
Russwurm M, Koesling D (2004) NO activation of guanylyl cyclase. Embo J 23(22):4443–4450
Russwurm M et al (1998) Functional properties of a naturally occurring isoform of soluble guanylyl cyclase. Biochem J 335(Pt 1):125–130
Russwurm M, Wittau N, Koesling D (2001) Guanylyl cyclase/PSD-95 interaction: targeting of the nitric oxide-sensitive alpha2beta1 guanylyl cyclase to synaptic membranes. J Biol Chem 276(48):44647–44652
Sayed N et al (2007) Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation. Proc Natl Acad Sci USA 104(30):12312–12317
Schrammel A et al (1996) Characterization of 1H-[1, 2, 4]oxadiazolo[4, 3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase. Mol Pharmacol 50(1):1–5
Semple-Rowland SL et al (1998) A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype. Proc Natl Acad Sci USA 95(3):1271–1276
Sitaramayya A (2002) Soluble guanylate cyclases in the retina. Mol Cell Biochem 230(1–2):177–186
Southam E, Garthwaite J (1993) The nitric oxide-cyclic GMP signalling pathway in rat brain. Neuropharmacology 32(11):1267–1277
Stasch JP et al (2001) NO-independent regulatory site on soluble guanylate cyclase. Nature 410(6825):212–215
Stone JR, Marletta MA (1994) Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states. Biochemistry 33(18):5636–5640
Stone JR, Marletta MA (1995) The ferrous heme of soluble guanylate cyclase: formation of hexacoordinate complexes with carbon monoxide and nitrosomethane. Biochemistry 34(50):16397–16403
Stone JR, Marletta MA (1996) Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide. Biochemistry 35(4):1093–1099
Stone JR, Marletta MA (1998) Synergistic activation of soluble guanylate cyclase by YC-1 and carbon monoxide: implications for the role of cleavage of the iron-histidine bond during activation by nitric oxide. Chem Biol 5(5):255–261
Stone JR et al (1995) Electron paramagnetic resonance spectral evidence for the formation of a pentacoordinate nitrosyl-heme complex on soluble guanylate cyclase. Biochem Biophys Res Commun 207(2):572–577
Wedel B et al (1994) Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase. Proc Natl Acad Sci USA 91(7):2592–2596
Wedel B et al (1995) Functional domains of soluble guanylyl cyclase. J Biol Chem 270(42):24871–24875
Yu H et al (1999) Activation of retinal guanylyl cyclase-1 by Ca2+-binding proteins involves its dimerization. J Biol Chem 274(22):15547–15555
Yuen PS, Potter LR, Garbers DL (1990) A new form of guanylyl cyclase is preferentially expressed in rat kidney. Biochemistry 29(49):10872–10878
Yuen PS, Doolittle LK, Garbers DL (1994) Dominant negative mutants of nitric oxide-sensitive guanylyl cyclase. J Biol Chem 269(2):791–793
Zhao Y, Marletta MA (1997) Localization of the heme binding region in soluble guanylate cyclase. Biochemistry 36(50):15959–15964
Zhao Y et al (1998) Structural changes in the heme proximal pocket induced by nitric oxide binding to soluble guanylate cyclase. Biochemistry 37(36):12458–12464
Zhao Y et al (1999) A molecular basis for nitric oxide sensing by soluble guanylate cyclase. Proc Natl Acad Sci USA 96(26):14753–14758
Zhu L, Gunn C, Beckman JS (1992) Bactericidal activity of peroxynitrite. Arch Biochem Biophys 298(2):452–457
Zwiller J, Revel MO, Malviya AN (1985) Protein kinase C catalyzes phosphorylation of guanylate cyclase in vitro. J Biol Chem 260(3):1350–1353
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Koesling, D., Sitaramayya, A. (2010). Soluble Guanylyl Cyclase: The Nitric Oxide Receptor. In: Sitaramayya, A. (eds) Signal Transduction: Pathways, Mechanisms and Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-02112-1_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-02112-1_18
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-02111-4
Online ISBN: 978-3-642-02112-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)